The first study in the world to take a detailed look at scar tissue in human pancreatic cancer has revealed a range of different scar tissue types that could help clinicians predict which patients will respond best to particular treatments.

The Institute of Cancer Research, London’s Enterprise Unit played host to scientists and possible future partners from the commercial sector to discuss opportunities to work together to defeat cancer.

A new test could improve care for patients with stomach or oesophageal cancer by predicting their likelihood of relapse after chemotherapy and surgery.